The Cure make a striking return to Billboard’s album charts (dated Nov. 16) with the arrival of Songs of a Lost World. It’s the band’s first No. 1 on the 33-year-old Top Album Sales chart and the act’s highest-charting effort on the Billboard 200 (No. 4) since 1992. It also bows at No. 1 on Top Rock & Alternative Albums, Top Rock Albums, Top Alternative Albums, Vinyl Albums and Indie Store Album Sales.

Songs of a Lost World is the group’s first album of new material since 2008. The new album is the act’s third top 10-charting set on the Billboard 200, following its self-titled effort (No. 7 in July 2004) and Wish (No. 2 in May 1992).

Equivalent album units comprise album sales, track equivalent albums (TEA) and streaming equivalent albums (SEA). Each unit equals one album sale, or 10 individual tracks sold from an album, or 3,750 ad-supported or 1,250 paid/subscription on-demand official audio and video streams generated by songs from an album. Nov. 16, 2024-dated charts will be posted in full on Billboard’s website on Tuesday, Nov. 12.

Songs of a Lost World bows with 57,000 equivalent album units earned (the act’s best week by units) in the United States in the week ending Nov. 7, according to Luminate. Of that sum, album sales comprise 53,000 (The Cure’s biggest sales week since 2004, when its self-titled album launched with 91,000), SEA units comprise 4,000 (equaling 5.02 million on-demand official streams of the album’s songs) and TEA units comprise a negligible sum.

The new album’s first-week sales were bolstered by its availability across five vinyl variants (which sold a combined 23,000 copies; the band’s best week on vinyl since Luminate began tracking sales in 1991), a standard CD, a CD/blu-ray audio package, two cassettes, a standard digital download and a deluxe digital download with five bonus live tracks (exclusive to the band’s webstore).

The set’s “A Fragile Thing” rises 25-22 on Alternative Airplay (a new peak and its highest charting song since 2004) and 12-10 on Adult Alternative Airplay (The Cure’s first top 10, and third charting hit, since the list began in 1996).